Natco Pharma completes acquisition of 35.75% stake in Adcock Ingram for ZAR 4B, delisting the 135-year-old SA pharma giant from JSE. Bidvest retains majority control.
Natco Pharma completes acquisition of 35.75% stake in Adcock Ingram for ZAR 4B, delisting the 135-year-old SA pharma giant from JSE. Bidvest retains majority control.
Business
